BTG3 and myeloid sarcoma: Additionally, low-titer antinuclear (ANA) and antiphospholipid antibodies are frequently found in the context of MS at variable frequencies ranging between 3%-–63% and 0.9%–8.5%, respectively (Spadaro et al., 1999; Szmyrka-Kaczmarek et al., 2012; Malyavantham et al., 2015; Merashli et al., 2017).